PTGS2 and cervical carcinoma: 16E5 inhibits apoptosis in cervical cancer cells by inducing the ubiquitination dependent degradation of the Bcl-2 family member, Bax, via a pathway dependent on COX-2, PGE2 and cyclic adenosine monophosphate (cAMP)-dependent protein kinase (PKA) [205].